Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Retained Earnings (2018 - 2025)

Dna X filings provide 8 years of Retained Earnings readings, the most recent being -$304.3 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 7.28% to -$304.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$304.3 million, a 7.28% decrease, with the full-year FY2025 number at -$304.3 million, down 7.28% from a year prior.
  • Retained Earnings hit -$304.3 million in Q4 2025 for Dna X, down from -$295.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$205.5 million in Q1 2021 to a low of -$304.3 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$249.8 million (2022), compared with a mean of -$254.7 million.
  • Biggest five-year swings in Retained Earnings: dropped 19.69% in 2021 and later increased 0.09% in 2023.
  • Dna X's Retained Earnings stood at -$234.8 million in 2021, then decreased by 6.42% to -$249.9 million in 2022, then fell by 0.04% to -$250.0 million in 2023, then fell by 13.46% to -$283.6 million in 2024, then decreased by 7.28% to -$304.3 million in 2025.
  • The last three reported values for Retained Earnings were -$304.3 million (Q4 2025), -$295.4 million (Q3 2025), and -$290.6 million (Q2 2025) per Business Quant data.